Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal vs Oral Diazepam for Levator Ani Syndrome
NCT04216797Phase 4Withdrawn
- Sponsor
- Swedish Health Services
- Start
- Jan 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diazepam in Levator Ani Syndrome (LAS) (2 arms), sponsored by Swedish Health Services. Primary endpoint: Visual Analog Scale at 10 weeks. Planned start Jan 2020; status: withdrawn.
02
Drugs
diazepam
03
Conditions
Levator Ani Syndrome (LAS)
Beyond the preview
Go deeper on NCT04216797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216797.